Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT (MRK:NYSE)

Merck & Co. (MRK) is close to an approximately $6 billion all-cash deal to buy US biotech firm Terns Pharmaceuticals (TERN) as it seeks to boost its drug pipeline ahead of cancer treatment Keytruda’s patent expiry, the Financial Times reported.

The talks

Source link

Financial News

U.N. shipping agency delays decision on ship fuel emissions tax after Trump pressureU.N. shipping agency delays decision on ship fuel emissions tax after Trump pressure

October 19, 2025 admin 0 Comments 8:37 am

U.N. shipping agency delays decision on ship fuel emissions tax after Trump pressure Source link{...}

Financial News

Top 2 Materials Stocks That Are Set To Fly This Quarter – Hongli Group (NASDAQ:HLP), Origin Materials (NASDAQ:ORGN)Top 2 Materials Stocks That Are Set To Fly This Quarter – Hongli Group (NASDAQ:HLP), Origin Materials (NASDAQ:ORGN)

January 10, 2026 admin 0 Comments 9:12 am

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies. The RSI is a{...}

Financial News

LNG project approvals set to push U.S. to process record volumes (NYSEARCA:UNG)LNG project approvals set to push U.S. to process record volumes (NYSEARCA:UNG)

June 25, 2023 admin 0 Comments 12:56 am

straga/iStock via Getty Images U.S. liquefied natural gas developers are on track to win approval of three new export projects{...}

Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT (MRK:NYSE)

Related Posts

U.N. shipping agency delays decision on ship fuel emissions tax after Trump pressureU.N. shipping agency delays decision on ship fuel emissions tax after Trump pressure

Top 2 Materials Stocks That Are Set To Fly This Quarter – Hongli Group (NASDAQ:HLP), Origin Materials (NASDAQ:ORGN)Top 2 Materials Stocks That Are Set To Fly This Quarter – Hongli Group (NASDAQ:HLP), Origin Materials (NASDAQ:ORGN)

LNG project approvals set to push U.S. to process record volumes (NYSEARCA:UNG)LNG project approvals set to push U.S. to process record volumes (NYSEARCA:UNG)